CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.15, sa.7, ss.535-540, 2013 (SCI İndekslerine Giren Dergi)
Small cell lung cancer (SCLC) has a high relapse rate despite being very chemosensitive. The efficacy of second-line treatment is dismal. Our aim was to evaluate the outcome of second-line treatment.